Healthcare & Life Sciences
Impel NeuroPharma
United Statesimpelnp.com
Impel NeuroPharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Impel NeuroPharma
Impel NeuroPharma is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Impel NeuroPharma develops intranasal drug delivery technologies, including the Precision Olfactory Delivery (POD) platform, to enable rapid and targeted delivery of therapeutics to the central nervous system for treating migraine and other neurological disorders.
Explore Impel NeuroPharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.